Forskolin prolongs action potential duration and blocks potassium current in embryonic chick sensory neurons

Insights

Forskolin, a cyclic adenosine monophosphate (cAMP) activator, increases action potential duration in chick sensory neurons by activating adenylate cyclase. This effect is distinct from norepinephrine

Area of Science:

  • Neuroscience
  • Cellular Biology
  • Pharmacology

Background:

  • Voltage-dependent ion channels are crucial for neuronal function.
  • Internal cyclic adenosine monophosphate (cAMP) levels can modulate these channels.
  • Embryonic chick sensory neurons provide a model for studying neuronal excitability.

Purpose of the Study:

  • To investigate the role of internal cyclic adenosine monophosphate (cAMP) in modulating voltage-dependent channels.
  • To determine if forskolin, an adenylate cyclase activator, affects neuronal action potential duration.
  • To compare the effects of forskolin with other modulators like capsaicin and norepinephrine.

Main Methods:

  • Application of forskolin and cholera toxin to embryonic chick sensory neurons in vitro.
  • Measurement of action potential duration and voltage-dependent outward currents.
  • Use of 2',5'-dideoxyadenosine to inhibit adenylate cyclase activity.
  • Voltage-clamp techniques to analyze membrane currents.

Main Results:

  • Forskolin caused dose-dependent, reversible increases in action potential duration.
  • The forskolin-induced effect was blocked by 2',5'-dideoxyadenosine, indicating adenylate cyclase involvement.
  • Cholera toxin also increased action potential duration.
  • Forskolin decreased voltage-dependent outward current in voltage-clamped neurons.
  • Forskolin's effects mimicked capsaicin but contrasted with norepinephrine's previously reported actions.

Conclusions:

  • Internal cAMP modulation, via adenylate cyclase activation, significantly impacts action potential duration in these neurons.
  • Forskolin's actions on voltage-dependent channels are distinct from those of norepinephrine.
  • Adenylate cyclase activation is likely not involved in norepinephrine's modulation of calcium channels.

Related Concept Videos

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Action Potential: Phases of Stimulation01:28

Action Potential: Phases of Stimulation

The action potential is a complex electrical event that occurs in excitable cells, such as neurons and muscle cells. It consists of several distinct phases, each with specific characteristics.
Resting Phase:
In this phase, the cell's membrane is at its resting potential, typically around -70 millivolts (mV) for neurons. Inside the cell, there is a higher concentration of potassium ions (K+) and a lower concentration of sodium ions (Na+). Voltage-gated sodium channels are closed, and...